Amesite secures new sales win targeting post-acute care organizations
What happened
Amesite announced a new sales win utilizing its minimum enterprise pricing model for post-acute care organizations. Under this model, the NurseMagic® Enterprise platform is priced at $1,099 per month for organizations with up to 1,000 patients under a 12-month contract. The company estimates that agreements at this level generate approximately 85% gross margin.
From manilatimes.net
Why it matters
The pricing model provides commercial validation for serving smaller post-acute care organizations while supporting scalable revenue growth. This follows previous announcements of 63% revenue growth from NurseMagic® Enterprise.
Roadzen and Amesite are newly listed on the Nasdaq stock exchange, and Roadzen operates as an insurance-as-a-service platform in the United States.
From manilatimes.net
Who's involved
- NasdaqThe stock exchange where Amesite is listed
Keep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
Related events
- Aaron was listed on the Nasdaq stock exchange today.
- Materialise listed its shares on the Nasdaq stock exchange on August 27, 2026.
- INmune Bio Inc. listed its shares on the stock exchange on July 9, 2026.
- Midwestone Financial Group (Carter Bank & Trust) is listed on Nasdaq and is receiving analyst ratings from MarketBeat.
- Crescent Capital BDC, Inc. stock traded on the Nasdaq exchange and filings were made with the SEC on May 27, 2026.